Clinical Trial Update: Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glufosfamide with or without hydration in patients with advanced pancreatic cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Glufosfamide (glufosfamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED